Neurociencia del consumo y dependencia de sustancias psicoactivas

More documents

Recommendations

Info

4. PSICOFARMACOLOGÍA DE LA DEPENDENCIA DE LAS DIFERENTES CLASES DE DROGASKalant H (1998) Research on tolerance: what can we learn from history?Alcoholism: Clinical and Experimental Research, 22:67–76.Kalant H (2001) The pharmacology and toxicology of “Ecstasy” (MDMA) andrelated drugs. Canadian Medical Association Journal, 165:917–928.Kalivas PW, Weber B (1988) Amphetamine injection into the ventral mesencephalonsensitizes rats to peripheral amphetamine and cocaine. Journal ofPharmacology and Experimental Therapeutics, 245:1095–1102.Kantak KM y colab. (2001) Time course of changes in cocaine self-administrationbehavior during immunization with the cocaine vaccine IPC-1010.Psychopharmacology, 153:334–340.Kenny PJ, Markou A (2001) Neurobiology of the nicotine withdrawal syndrome.Pharmacology, Biochemistry and Behavior, 70:531–549.Khanolkar AD, Palmer SL, Makriyannis A (2000) Molecular probes for thecannabinoid receptors. Chemistry and Physics of Lipids, 108:37–52.Kieffer BL (1999) Opioids: first lessons from knock-out mice. Trends inPharmacological Sciences, 20:537–544.Kieffer BL, Evans CJ (2002) Opioid tolerance: in search of the holy grail. Cell,108:587–590.Kita K y colab. (1999) Effects of D1 and D2 dopamine receptor antagonists oncocaine-induced self-stimulation and locomotor activity in rats. EuropeanNeuropsychopharmacology, 9:1–7.Knisely JS, Rees DC, Balster RL (1990) Discriminative stimulus properties oftoluene in the rat. Neurotoxicology and Teratology, 12:129–133.Koob GF (1992) Neural mechanisms of drug reinforcement. Annals of the NewYork Academy of Sciences, 28:171–191.Koob GF (1995) Animal models of drug addiction. Psychopharmacology: TheFourth Generation of Progress, 66:759–772.Koob GF and Bloom FE (1988) Cellular and molecular mechanisms of drugdependence. Science, 42:715–723.Koob GF and Nestler EJ (1997) The neurobiology of drug addiction. Journal ofNeuropsychiatry and Clinical Neuroscience, 9:482–497.Kornetsky C y colab. (1988) Brain stimulation reward: effects of ethanol.Alcoholism: Clinical and Experimental Research, 12:609–616.Kosten TR y colab. (2002) Human therapeutic cocaine vaccine: safety andimmunogenicity. Vaccine, 20:1196–1204.Krambeer LL y colab. (2001) Methadone therapy for opioid dependence.American Family Physician, 15:2404–2410.Kranzler HR (2000) Pharmacotherapy of alcoholism: gaps in knowledge andopportunities for research. Alcohol and Alcoholism, 35:537–547.Krausz M (2002): Modellprojekt: heroin als medicament [Modelo de proyecto:Heroína como medicación]. Deutsches Ärzteblatt, 99:A26–A28.Kreek MJ (2000) Methadone-related opioid agonist pharmacotherapy for heroinaddiction: history, recent molecular and neurochemical research and future in115
NEUROCIENCIA DEL CONSUMO Y DEPENDENCIA DE SUSTANCIAS PSICOACTIVASmainstream medicine. Annals of the New York Academy of Sciences, 909:186-216.Kuczenski R, Segal DS (1992) Differential effects of amphetamine anddopamine uptake blockers (cocaine, nomifensine) on caudate and accumbensdialysate dopamine and 3-methoxytyramine. Journal of Pharmacology andExperimental Therapeutics, 262:1085–1094.Kuhar MJ y colab. (2001) Anticocaine catalytic antibodies have no affinity forRTI compounds: implications for treatment. Synapse, 41:176–178.Lahti AC y colab. (1995) Ketamine activates psychosis and alters limbic bloodflow in schizophrenia. Neuroreport, 6:869–782.Leshner AI, Koob GF (1999) Drugs of abuse and the brain. Proceedings of theAssociation of American Physicians, 111:99–108.Ling W y colab. (1998) Buprenorphine maintenance treatment of opiatedependence: a multicenter, randomized clinical trial. Addiction, 93:475–486.Lodge D, Johnson KM (1990) Noncompetitive excitatory amino acid receptorantagonists. Trends in Pharmacological Sciences, 11:81–86.Luisada PV (1978) The phencyclidine psychosis: phenomenology and treatment.NIDA Research Monograph, 21:241–253.Lukas RJ y colab. (1999) Current status of the nomenclature for nicotinic acetylcholinereceptors and their subunits. Pharmacological Reviews, 51:397–401.McBride WJ (2002) Central nucleus of the amygdala and the effects of alcoholand alcohol-drinking behavior in rodents. Pharmacology, Biochemistry andBehavior, 71:509–515.McBride WJ, Li TK (1998) Animal models of alcoholism: neurobiology of highalcohol-drinking behavior in rodents. Critical Reviews in Neurobiology, 12:339–369.McCance-Katz EF, Kosten TR, Jatlow P (1998) Concurrent use of cocaine andalcohol is more potent and potentially more toxic than use of either alone: a multiple-dosestudy. Biological Psychiatry, 44:250–259.McCann U, Ricaurte G (1991) Lasting neuropsychiatric sequelae of methylenedioxymethamphetamine("Ecstasy") in recreational users. Journal of ClinicalPsychopharmacology, 11:302–305.Maccarrone M y colab. (1998) Anandamide hydrolysis by human cells in cultureand brain. Journal of Biological Chemistry, 273:32 332–32 339.McKenna DJ, Peroutka SJ (1990) Neurochemistry and neurotoxicity of 3,4-methylenedioxymethamphetamine, MDMA ("Ecstasy"). Journal ofNeurochemistry, 54:14–22.Maldonado R, Rodriguez de Fonseca F (2002) Cannabinoid addiction: behaviouralmodels and neural correlates. Journal of Neuroscience, 22:3326–3331.Malin DH (2001) Nicotine dependence studies with a laboratory model.Pharmacology, Biochemistry and Behavior, 70:551–559.Mansour A, Watson SJ (1993) Anatomical distribution of opioid receptors in mammalian:an overview. En: Hertz A, ed. Opioids I. Berlín, Springer-Verlag:79–105.Mansour A y colab. (1995) Opioid-receptor mRNA expression in the rat CNS:anatomical and functional implications. Trends in Neuroscience, 18:22–29.116
Page 1:
Neurociencia del consumoy dependenc
Page 4 and 5:
ÍndiceÍndicePrólogoAgradecimient
Page 6 and 7:
ÍNDICESedantes e hipnóticos 73Int
Page 8 and 9:
ÍNDICEFenotipo 148Comorbilidad 148
Page 10 and 11:
PrólogoEl uso y dependencia de sus
Page 12:
AgradecimientosLa Organización Mun
Page 22 and 23:
Capítulo 1IntroducciónEl presente
Page 25 and 26:
NEUROCIENCIA DEL CONSUMO Y DEPENDEN
Page 27 and 28:
Page 29 and 30:
Page 31 and 32:
Page 33 and 34:
Page 35 and 36:
Page 37 and 38:
Page 39 and 40:
Page 42 and 43:
2. MECANISMOS CEREBRALES: NEUROBIOL
Page 44 and 45:
Page 46 and 47:
Page 48 and 49:
Page 51 and 52:
Page 53 and 54:
Page 55 and 56:
Page 57 and 58:
Page 59 and 60:
Page 61 and 62:
Page 63 and 64:
Page 65 and 66:
Page 67 and 68:
Page 69 and 70:
Page 71 and 72:
Page 73 and 74:
Page 75 and 76:
Page 77 and 78:
Page 79 and 80:
Page 81 and 82:
Page 83 and 84:
Page 85 and 86: NEUROCIENCIA DEL CONSUMO Y DEPENDEN
Page 88 and 89: Capítulo 4Psicofarmacología de la
Page 90 and 91: 4. PSICOFARMACOLOGÍA DE LA DEPENDE
Page 146 and 147: Capítulo 5Bases Genéticas de lasF
Page 148 and 149: 5. BASES GENÉTICAS DE LAS FARMACOD
Page 186 and 187:
5. BASES GENÉTICAS DE LAS FARMACOD
Page 188 and 189:
5. BASES GENÉTICAS DE LAS FARMACOD
Page 190 and 191:
Capítulo 6Trastornos ConcurrentesI
Page 192 and 193:
6. TRASTORNOS CONCURRENTES3. El uso
Page 194 and 195:
6. TRASTORNOS CONCURRENTESy Meador-
Page 196 and 197:
6. TRASTORNOS CONCURRENTESprobablem
Page 198 and 199:
6. TRASTORNOS CONCURRENTESde drogas
Page 200 and 201:
6. TRASTORNOS CONCURRENTESy Turski,
Page 202 and 203:
6. TRASTORNOS CONCURRENTESEl víncu
Page 204 and 205:
6. TRASTORNOS CONCURRENTESAlcohol y
Page 206 and 207:
6. TRASTORNOS CONCURRENTESSerotonin
Page 208 and 209:
6. TRASTORNOS CONCURRENTESFunción
Page 210 and 211:
6. TRASTORNOS CONCURRENTESRECUADRO
Page 212 and 213:
6. TRASTORNOS CONCURRENTEStos psiqu
Page 214 and 215:
6. TRASTORNOS CONCURRENTESCarol G y
Page 216 and 217:
6. TRASTORNOS CONCURRENTESdepressio
Page 218 and 219:
6. TRASTORNOS CONCURRENTESHall RG y
Page 220 and 221:
6. TRASTORNOS CONCURRENTESKapur S,
Page 222 and 223:
6. TRASTORNOS CONCURRENTESMansvelde
Page 224 and 225:
6. TRASTORNOS CONCURRENTESPetty F (
Page 226 and 227:
6. TRASTORNOS CONCURRENTESSevy S y
Page 228:
6. TRASTORNOS CONCURRENTESlesions o
Page 231 and 232:
Page 233 and 234:
Page 235 and 236:
Page 237 and 238:
Page 239 and 240:
Page 241 and 242:
Page 243 and 244:
Page 245 and 246:
Page 247 and 248:
Page 249 and 250:
Page 251 and 252:
Page 253 and 254:
Page 255 and 256:
Page 257 and 258:
Page 259 and 260:
Page 261 and 262:
Page 263 and 264:
Page 265 and 266:
Page 267 and 268:
Page 269 and 270:
Page 272 and 273:
Índice AnalíticoNota: los número
Page 274 and 275:
ÍNDICE ANALÍTICOAtropina 103ATV,
Page 276 and 277:
ÍNDICE ANALÍTICOpolíticas de sal
Page 278 and 279:
ÍNDICE ANALÍTICOuso de tabaco 171
Page 280 and 281:
ÍNDICE ANALÍTICOInmunoterapias pa
Page 282 and 283:
ÍNDICE ANALÍTICOParkinson, efecto
Page 284 and 285:
ÍNDICE ANALÍTICOSolventes voláti
Page 286:
Neurociencia del consumo y dependen
show all

Neurociencia del consumo y dependencia de sustancias psicoactivas

Create successful ePaper yourself

Delete template?

Save as template?